Hi Hottod. I have to agree with Upxdn Thanks for sharing your excellent research.
It certainly at least opens up the possibility that we could demonstrate our superior delivery of their product to the desired cell type, and if we did so there could be two interested parties both with substantial cash and market caps who both may want access.
And all that while still working on other possible platform uses such as vaccines and myc delivery. The beauty of the platform approach may be starting to emerge?
Hi Hottod. I have to agree with Upxdn Thanks for sharing your...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |